Amdocs DOX 深 滬
已收盤 10-31 16:00:00 美东时间
84.26
+0.410
+0.49%
華盛通- 最 高84.56
- 今 開83.66
- 成交量 78.72万股
- 最 低 83.335
- 昨 收 83.85
- 總市值 93.53亿
- 52周最高 94.3559
- 市盈率 靜 19.84
- 換手率 0.00%
- 52周最低 77.556
- 委 比 88.94%
- 總股本 1.11亿
- 歷史最高 95.383
- 量 比 0.90
- 振 幅 1.46%
- 歷史最低 10.898
- 每 手 1
- 風險率 3.08%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Similarweb names Ran Vered as CFO
Similarweb (SMWB) said on Monday it has appointed Ran Vered as chief financial officer, effective December 21, 2025. Vered previously served as CFO of Lusha, Ceragon Networks (NASDAQ:CRNT) and Radcom ...
10-27 19:56
Integrae SIM Sticks to Their Buy Rating for Doxee S.p.A. (DOX)
In a report released yesterday, Mattia Petracca from Integrae SIM maintained a ...
10-01 18:45
Optimum inks multi-year agreement with Amdocs for AI-Driven modernization
Amdocs (NASDAQ:DOX) on Wednesday said it has signed a multi‑year agreement with Optimum to extend its managed services engagement and accelerate business transformation using Amdocs’ AI-native solutio...
09-10 21:32
Amdocs Signs Multi‑Year Agreement To Extend And Deepen Managed Transformation Initiative Using Amdocs' AI Offerings
Powered by Amdocs' AI-native solutions, the agreement extends and expands Amdocs' managed services engagement for Optimum's broadband and video services productsJERSEY CITY, NJ / ACCESS Newswire / September 10, 2025 /
09-10 20:11
Amdocs Reports Decline in Q2 2025 Revenue
Amdocs ( ($DOX) ) has issued an announcement. Amdocs Limited reported its finan...
08-19 04:27
'Amdocs to lay off hundreds to adjust to AI'- Globes
https://en.globes.co.il/en/article-amdocs-to-lay-off-hundreds-to-adjust-to-ai-1001518735
08-12 22:09
Amdocs declares $0.527 dividend
Amdocs (NASDAQ:DOX) declares $0.527/share quarterly dividend, in line with previous. Forward yield 2.37% Payable Oct. 31; for shareholders of record Sept. 30; ex-div Sept. 30. See DOX Dividend Scoreca...
08-08 21:29
Moleculin Highlights Preclinical Data For Annamycin In Liver Cancers, Reinforcing Late-Stage AML Development And Broad Oncology Potential
Presented data highlights the potential of Annamycin for treating broad range of human cancers, including high-need oncology indications Annamycin currently in late-stage clinical development in combination with
08-06 20:45
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
Doxee S.p.A. Announces Share Capital Increase Following Stock Grant Plan
Doxee S.p.A. ( ($IT:DOX) ) has issued an announcement. Doxee S.p.A. announced t...
07-28 23:23
